http://www.advfn.com/nasdaq/rss.asp?symbol=IMGN Immunogen Company Newsfeed en Fri, 22 Feb 2013 12:20:15 EST Fri, 22 Feb 2013 12:20:15 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=56422894&headline=fda-approves-breast-cancer-drug http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=56422894&headline=fda-approves-breast-cancer-drug <div class='newsbody'><p> WASHINGTON--The U.S. Food and Drug Administration Friday approved a powerful new type of drug that will be marketed by Roche Holding AG (ROG.VX, RHHBY) to treat breast cancer. </p> <p> The drug called, Kadcyla, combines Roche's existing cancer drug, Herceptin, with a powerful... Fri, 22 Feb 2013 12:20:15 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=56422239&headline=fda-approves-kadcyla-breast-cancer-drug-from-roche-immunogen http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=56422239&headline=fda-approves-kadcyla-breast-cancer-drug-from-roche-immunogen <div class='newsbody'><pre> By Jennifer Corbett Dooren </pre> <p> WASHINGTON--The U.S. Food and Drug Administration Friday approved a powerful new type of drug that will be marketed by Roche Holding AG (ROG.VX, RHHBY) to treat breast cancer. </p> <p> The drug called, Kadcyla, combines Roche's existing... Fri, 22 Feb 2013 11:40:34 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=54905291&headline=u-s-hot-stock-futures-hot-stocks-to-watch http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=54905291&headline=u-s-hot-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies with shares expected to actively trade in Wednesday's session are VirnetX Holding Corp. (VHC), Plexus Corp. (PLXS) and SodaStream International Ltd. (SODA). </p> <p> A federal jury in Texas on Tuesday ordered Apple to pay patent holding firm VirnetX $368... Wed, 07 Nov 2012 12:39:53 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=54889462&headline=fda-gives-priority-review-to-immunogen-roche-breast-cancer-drug http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=54889462&headline=fda-gives-priority-review-to-immunogen-roche-breast-cancer-drug <div class='newsbody'><pre> By Kristin Jones </pre> <p> The U.S. Food and Drug Administration has granted priority review to an investigational breast cancer treatment that is being developed by Genentech and ImmunoGen Inc. (IMGN), the companies said. </p> <p> The drug, trastuzumab emtansine, is in global... Tue, 06 Nov 2012 18:06:12 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=53950711&headline=immunogen-breast-cancer-drug-shows-positive-results-shares-up http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=53950711&headline=immunogen-breast-cancer-drug-shows-positive-results-shares-up <div class='newsbody'><pre> By Saabira Chaudhuri </pre> <p> ImmunoGen Inc. (IMGN) said updated results from a study by Roche Holding AG (ROG.VX, RHHBY, RO.EB) focused on a breast cancer drug that uses ImmunoGen's technology were positive. </p> <p> Shares jumped 23% to $17 in recent premarket trading... Mon, 27 Aug 2012 08:28:12 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=50494892&headline=correct-immunogen-to-collaborate-with-lilly-on-cancer-drugs http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=50494892&headline=correct-immunogen-to-collaborate-with-lilly-on-cancer-drugs <div class='newsbody'><p> ("CORRECT: ImmunoGen To Collaborate With Lilly On Cancer Drugs" published at 10:37 a.m. ET, misstated the amount of potential milestone payments in the first paragraph. The correct version follows:) </p> <pre> DOW JONES NEWSWIRES </pre> <p> ImmunoGen Inc. (IMGN) agreed to a... Tue, 20 Dec 2011 12:53:08 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=50490779&headline=us-stock-futures-hot-stocks-to-watch http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=50490779&headline=us-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies whose shares are expected to actively trade in Tuesday's session are General Mills Inc. (GIS), AT&amp;T Inc. (T) and Navistar International Corp.'s (NAV). </p> <p> General Mills's fiscal second-quarter earnings fell 28% as higher costs continued to outpace... Tue, 20 Dec 2011 09:18:02 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=50488754&headline=immunogen-to-collaborate-with-lilly-on-cancer-drugs http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=50488754&headline=immunogen-to-collaborate-with-lilly-on-cancer-drugs <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> ImmunoGen Inc. (IMGN) agreed to a collaboration with Eli Lilly &amp; Co. (LLY) potentially valued at roughly $220 million in which the pharmaceutical giant will get exclusive licensing rights to some of the drug developer's antibody-based cancer... Tue, 20 Dec 2011 07:34:12 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=45612008&headline=immunogen-roche-breast-cancer-drug-has-positive-response-in-early http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=45612008&headline=immunogen-roche-breast-cancer-drug-has-positive-response-in-early <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Immunogen Inc. (IMGN) said Friday a breast-cancer treatment it is developing with Roche Holding AG (RHHBY, ROG.VX) improved the condition of more than half the patients of an early-stage study when tested with another Roche drug. </p> <p> The Phase... Fri, 10 Dec 2010 19:32:18 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=44734961&headline=immunogen-cuts-year-forecast-announces-positive-study-results http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=44734961&headline=immunogen-cuts-year-forecast-announces-positive-study-results <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> ImmunoGen Inc. (IMGN) cut its bottom-line expectations for the current fiscal year on potential higher expenses to develop drugs. </p> <p> The guidance cut comes as the drug maker on Monday also announced a collaboration with Switzerland's Novartis... Mon, 11 Oct 2010 07:30:09 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=44732263&headline=novartis-and-immunogen-to-co-produce-cancer-drugs http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=44732263&headline=novartis-and-immunogen-to-co-produce-cancer-drugs <div class='newsbody'><p> By Goran Mijuk </p> <p> Of DOW JONES NEWSWIRES </p> <p> ZURICH -(Dow Jones)- Switzerland's Novartis AG (NVS) and U.S.-based Immunogen Inc (IMGN) Monday said they signed a collaboration deal to develop novel cancer treatments. </p> <p> As part of the collaboration, Immunogen... Mon, 11 Oct 2010 04:43:44 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=44059342&headline=immunogen-receives-orphan-drug-status-for-lung-cancer-drug http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IMGN&article=44059342&headline=immunogen-receives-orphan-drug-status-for-lung-cancer-drug <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> ImmunoGen Inc.'s (IMGN) lorvotuzumab mertasine received orphan-drug status as a treatment for small-cell lung cancer from the Food and Drug Administration. </p> <p> Shares climbed on the news and were recently up 2.7% at $9.28. </p> <p> The FDA designation... Wed, 18 Aug 2010 13:45:05 EDT